The Bengaluru-based Neuome Technologies has announced the development and launch of Nemo, an ambient air quality monitoring device for detecting SARS-CoV-2.
The device is intended to be used within closed spaces such as hospitals, restaurants, schools, offices, technology parks, malls, airports, bus stations etc. It helps provide an assurance of safety and alerts to take necessary action in case of the presence of SARS-CoV-2 virus in the air for selective evacuation and decontamination, as required.
Nemo uses a combination of nanotechnology and bioelectronics to quickly detect SARS-CoV-2 in the air with a sensitivity of as low as 200 viral particles. The nanosensors developed at Neuome Technologies can quickly change the color in presence of the virus and alert the maintenance personnel to take remedial action rapidly before the virus can spread. The technology can be adapted to be placed in the air vent/duct, as well.
“Neuome Technologies strives for innovation and is very glad to develop this device to open up the economy in midst of the pandemic, as a solution developed in India, by India, for India. A true Atmanirbhar Bharat. We also thank Bengaluru Bioinnovation Centre, for its support,” said Dr Rajanikanth Vangala, Managing Director & CEO, Neuome Technologies, in a statement.
Monitoring Indoor air quality is critical, especially in places such as hospitals, educational institutes, workspaces and public transport systems. It is very clear that asymptomatic or symptomatic infected people can shed the virus through aerosols, which can quickly spread through breathing the same air or contacting the surface where they are deposited. There are no available technologies which can identify quickly the areas contaminated in the enclosed spaces.
Founded in 2020, Neuome Technologies Private Limited is a niche biotech innovation startup incubated at Helix Biotech Park, Bangalore Bioinnovation Centre, Bengaluru.